Author

Pavanish Kumar

SingHealth Duke-NUS Academic Medical CentreORCID 0000-0003-1832-4436Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Research Focus:clustering· 2 Research Focus:differential expression· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Approach:deep learning· 1 Approach:experimental assay· 1

Frequent Co-Authors

Salvatore AlbaniiD· 2 shared Alicia TayiD· 1 shared Basil Kuok Zi XiiD· 1 shared Chong Xiang TaniD· 1 shared Elisavet Kalaitsidou· 1 shared Germaine Teng· 1 shared Giulia AdrianiiD· 1 shared Giulio GiustariniiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Salvatore AlbaniORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyThe Journal of ImmunologyPeer-reviewedApr 1, 2026

CyNET- a network analysis framework for high dimensionality, system level analyses of the functional Immunome

Pavanish Kumar, Joo Guan Yeo, Su Li Poh…·Salvatore Albani

CyNET analyzes immune system networks to identify functional hubs and maturation patterns across age groups using single-cell transcriptomics.

1 citation

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMar 9, 2026

Multi-omics and functional analysis of a bioengineered vascularized pancreatic cancer model reveal an immunosuppressive and therapy-resistant niche

Giulio Giustarini, Kok Siong Ang, Pavanish Kumar…·Giulia Adriani

The paper develops a bioengineered vascularized pancreatic cancer model and uses multi-omics and functional assays to reveal an immunosuppressive and therapy-resistant tumor niche.

1 citation

𝕏 PostBluesky